Aptus Capital Advisors LLC Purchases 10,082 Shares of Arcosa, Inc. (NYSE:ACA)

Aptus Capital Advisors LLC grew its stake in shares of Arcosa, Inc. (NYSE:ACA - Free Report) by 15.5% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 74,976 shares of the company's stock after purchasing an additional 10,082 shares during the period. Aptus Capital Advisors LLC owned about 0.15% of Arcosa worth $7,105,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. The Manufacturers Life Insurance Company increased its stake in Arcosa by 1.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 553,157 shares of the company's stock valued at $46,139,000 after buying an additional 6,673 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Arcosa by 2.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 456,066 shares of the company's stock valued at $38,040,000 after purchasing an additional 9,602 shares during the last quarter. Russell Investments Group Ltd. raised its stake in shares of Arcosa by 6.9% during the 1st quarter. Russell Investments Group Ltd. now owns 294,928 shares of the company's stock worth $25,323,000 after purchasing an additional 18,967 shares during the period. Boston Partners boosted its holdings in shares of Arcosa by 272.6% in the 1st quarter. Boston Partners now owns 220,961 shares of the company's stock worth $18,947,000 after buying an additional 161,662 shares during the last quarter. Finally, Harbor Capital Advisors Inc. increased its holdings in Arcosa by 152.2% during the third quarter. Harbor Capital Advisors Inc. now owns 195,358 shares of the company's stock worth $18,512,000 after buying an additional 117,892 shares during the last quarter. 90.66% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Arcosa news, Director Steven J. Demetriou bought 6,000 shares of Arcosa stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average cost of $87.70 per share, for a total transaction of $526,200.00. Following the completion of the transaction, the director now directly owns 9,943 shares in the company, valued at $872,001.10. This represents a 100.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. In other Arcosa news, insider Bryan Stevenson sold 4,000 shares of Arcosa stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $83.78, for a total transaction of $335,120.00. Following the completion of the sale, the insider now owns 35,333 shares of the company's stock, valued at $2,960,198.74. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Steven J. Demetriou acquired 6,000 shares of Arcosa stock in a transaction dated Thursday, September 12th. The shares were purchased at an average price of $87.70 per share, for a total transaction of $526,200.00. Following the completion of the transaction, the director now directly owns 9,943 shares in the company, valued at approximately $872,001.10. The trade was a 100.00 % increase in their position. The disclosure for this purchase can be found here. 1.30% of the stock is currently owned by insiders.

Arcosa Stock Performance

Shares of ACA stock traded down $0.40 during trading on Wednesday, reaching $103.18. 227,680 shares of the company's stock traded hands, compared to its average volume of 240,371. Arcosa, Inc. has a 1 year low of $71.89 and a 1 year high of $107.79. The company has a market capitalization of $5.03 billion, a P/E ratio of 39.23 and a beta of 0.71. The company has a current ratio of 3.61, a quick ratio of 2.77 and a debt-to-equity ratio of 0.51. The firm's 50-day moving average is $93.89 and its 200 day moving average is $88.51.

Arcosa (NYSE:ACA - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.13. Arcosa had a return on equity of 6.64% and a net margin of 5.17%. The company had revenue of $640.40 million during the quarter, compared to analysts' expectations of $682.52 million. During the same period in the previous year, the business earned $0.73 earnings per share. The firm's quarterly revenue was up 8.2% compared to the same quarter last year. Equities research analysts expect that Arcosa, Inc. will post 3.38 EPS for the current year.

Arcosa Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th were given a $0.05 dividend. The ex-dividend date was Tuesday, October 15th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.19%. Arcosa's dividend payout ratio (DPR) is currently 7.60%.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on ACA shares. Stephens upgraded shares of Arcosa from an "equal weight" rating to an "overweight" rating and set a $96.00 target price on the stock in a research note on Wednesday, August 7th. Oppenheimer increased their price objective on Arcosa from $100.00 to $105.00 and gave the company an "outperform" rating in a report on Monday, August 19th. Finally, Barclays assumed coverage on Arcosa in a research note on Tuesday, October 29th. They issued an "overweight" rating and a $106.00 target price on the stock.

Arcosa Company Profile

Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.